Erlotinib or Gefitinib for Non-Small-Cell Lung Cancer

被引：0
|
作者：
Kaye, Frederic J. [1 ]
Jantz, Michael A. [1 ]
Dallas, Jennifer [1 ]
机构：
[1] Univ Florida, Coll Med, Gainesville, FL 32611 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2011年 / 364卷 / 24期
关键词：
RECHALLENGE; DISEASE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2367 / 2367
页数：1
相关论文
共 50 条
  • [41] Role of Gefitinib in Patients with Non-small-cell Lung Cancer in India
    Mehta, Asmita Anilkumar
    Jose, Wesley M.
    Pavithran, Kicheelath
    Triavadi, Ganesan S.
    INDIAN JOURNAL OF PALLIATIVE CARE, 2013, 19 (01) : 48 - 53
  • [42] Gefitinib: A new antineoplastic for advanced non-small-cell lung cancer
    Cersosimo, RJ
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (09) : 889 - 898
  • [43] Optimizing response to gefitinib in the treatment of non-small-cell lung cancer
    Carotenuto, Pietro
    Roma, Cristin
    Rachiglio, Anna Maria
    Pasquale, Raffaella
    Franco, Renato
    Antinolfi, Giuseppe
    Piantedosi, Francovito
    Illiano, Alfonso
    Botti, Gerardo
    Morabito, Alessandro
    Normanno, Nicola
    De Luca, Antonella
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2011, 4 : 1 - 9
  • [44] Gefitinib maintenance in stage III non-small-cell lung cancer
    Stewart, David J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (29) : 4849 - 4850
  • [45] APL during gefitinib treatment for non-small-cell lung cancer
    Uchida, A
    Matsuo, K
    Tanimoto, M
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (08): : 843 - 843
  • [46] Gefitinib in recurrent non-small-cell lung cancer: An IDEAL trial?
    Johnson, DH
    Arteaga, CL
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) : 2227 - 2229
  • [47] Gefitinib for Chinese patients with advanced non-small-cell lung cancer
    Xiaotong, Z
    Longyun, L
    Xinlin, MU
    LUNG CANCER, 2004, 45 : S79 - S79
  • [48] EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
    Kobayashi, S
    Boggon, TJ
    Dayaram, T
    Janne, PA
    Kocher, O
    Meyerson, M
    Johnson, BE
    Eck, MJ
    Tenen, DG
    Halmos, B
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (08): : 786 - 792
  • [49] Second-line erlotinib for non-small-cell lung cancer
    Lorusso, Vito
    Cinieri, Saverio
    LANCET ONCOLOGY, 2012, 13 (04): : E141 - E142
  • [50] Comparison of adverse events and efficacy between gefitinib and erlotinib in patients with non-small-cell lung cancer: a retrospective analysis
    Yoshida, Tsukasa
    Yamada, Kazuhiko
    Azuma, Koichi
    Kawahara, Akihiko
    Abe, Hideyuki
    Hattori, Satoshi
    Yamashita, Fumie
    Zaizen, Yoshiaki
    Kage, Masayoshi
    Hoshino, Tomoaki
    MEDICAL ONCOLOGY, 2013, 30 (01)
12345